Deborah L. Weitzman

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Deborah L. Weitzman

Deborah L. Weitzman is recorded as CEO at Cardinal Health Inc (CAH). The proxy statement of Cardinal Health Inc reports total compensation of $6,120,157 for Deborah L. Weitzman in fiscal 2026, including a base salary of $770,479. Disclosed compensation is on record for 4 fiscal years.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Explain Deborah L. Weitzman's disclosed executive compensation over time and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cardinal Health Inc (CAH)
CEO

Proxy statement

Current
Start not stated–present

Company network

Recorded roles and call appearances connecting this person to public companies.

Cardinal Health Inc

CAH

Current role

CEO

Leadership on record at Cardinal Health Inc

Other people whose current roles at this company are on record from its filings.

Debbie Weitzman CEO
Jason Hollar CEO
Jason M. Hollar CEO, CFO, Board Member
Stephen M. Mason CEO
Patricia A. Hemingway Hall Chairman
Aaron E. Alt CFO
David C. Evans CFO, Board Member
Patricia M. English CFO, Chief Accounting Officer
Anita Zielinski Chief Accounting Officer
Mary C. Scherer Chief Accounting Officer

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2026	Cardinal Health Inc (CAH)	Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment	$770,479	—	$4,064,943	—	$1,254,340	$30,395	$6,120,157
2025	Cardinal Health Inc (CAH)	Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment	$741,932	—	$3,771,217	—	$964,511	$30,197	$5,507,857
2024	Cardinal Health Inc (CAH)	Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment	$709,153	—	$3,598,977	—	$758,794	$21,923	$5,088,847
2023	Cardinal Health Inc (CAH)	Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment	$606,139	—	$2,672,523	—	$773,979	$19,020	$4,071,661

Recent activity

No call appearances or filed executive changes recorded yet.